Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Len Schleifer
Pharma
JPM25: Regeneron has few answers for declining sales of Eylea HD
Regeneron had little explanation for a decline in sales of Eylea HD from $392 million in 2024's third quarter to $305 million in the fourth quarter.
Kevin Dunleavy
Jan 14, 2025 10:25am
Without equity awards, Regeneron's Schleifer made $7M in 2022
Apr 24, 2023 10:32am
Legendary Regeneron chairman Roy Vagelos to retire at age 93
Apr 17, 2023 10:34am
FDA approves Regeneron's Eylea for retinopathy of prematurity
Feb 9, 2023 11:18am
Regeneron looks forward to launch of longer-lasting Eylea
Feb 3, 2023 12:38pm
Eylea sales disappoint in Q4, Regeneron says its a 'blip'
Jan 9, 2023 3:15pm
